JP Morgan Chase’s CNOVA N.V. CNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-100,286
Closed -$550K 5397
2016
Q4
$550K Buy
100,286
+15,821
+19% +$86K ﹤0.01% 3722
2016
Q3
$454K Hold
84,465
﹤0.01% 3433
2016
Q2
$418K Buy
+84,465
New +$358K ﹤0.01% 3498
2016
Q1
Sell
-97,246
Closed -$234K 5153
2015
Q4
$234K Hold
97,246
﹤0.01% 3614
2015
Q3
$294K Buy
97,246
+259
+0.3% +$1.21K ﹤0.01% 3588
2015
Q2
$536K Buy
96,987
+74,356
+329% +$444K ﹤0.01% 3536
2015
Q1
$142K Buy
22,631
+8,020
+55% +$52.8K ﹤0.01% 3881
2014
Q4
$116K Buy
+14,611
New +$105K ﹤0.01% 4090

Other funds holding CNV

JP Morgan Chase's CNV Position: Q1 2017 in Review

JP Morgan Chase sold out of CNOVA N.V. (CNV) in Q1 2017, closing a stake of 100,286 shares — an estimated $550K sold.

JP Morgan Chase first reported a position in CNV in Q4 2014 and held it in 8 quarters. The position peaked at $550K in Q4 2016. 2 funds tracked by Wall St. Rank hold CNV as of Q1 2017.

  • JP Morgan Chase reported no remaining CNOVA N.V. position as of Q1 2017 after selling out during the quarter.
  • JP Morgan Chase sold 100,286 CNOVA N.V. shares in Q1 2017, an estimated $550K.
  • JP Morgan Chase first reported a position in CNOVA N.V. in Q4 2014 and held it in 8 quarters.
  • JP Morgan Chase's CNOVA N.V. position peaked at $550K in Q4 2016.
  • 2 funds tracked by Wall St. Rank held CNOVA N.V. as of Q1 2017.

Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.